All Stories

  1. 2020 international consensus on ANCA testing beyond systemic vasculitis

    Article • Autoimmunity Reviews, September 2020, Elsevier

    Dr Stephen P McAdoo

  2. Anti–glomerular basement membrane disease during the COVID-19 pandemic

    Article • Kidney International, September 2020, Elsevier

    Dr Stephen P McAdoo

  3. Live Imaging of Monocyte Subsets in Immune Complex-Mediated Glomerulonephritis Reveals Distinct Phenotypes and Effector Functions

    Article • Journal of the American Society of Nephrology, August 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  4. Oral potassium binders: increasing flexibility in times of crisis

    Article • Nephrology Dialysis Transplantation, August 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  5. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening

    Article • Journal of the American Society of Nephrology, July 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  6. A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  7. New Therapeutic Targets in ANCA‐associated Vasculitis

    Article • Arthritis & Rheumatology, June 2020, Wiley

    Dr Stephen P McAdoo

  8. Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model

    Article • Kidney International, June 2020, Elsevier

    Dr Stephen P McAdoo

  9. A Case Series of Patients with Isolated IgG4-related Hypophysitis Treated with Rituximab

    Article • Journal of the Endocrine Society, April 2020, Endocrine Society

    Dr Stephen P McAdoo

  10. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?

    Article • Journal of the American Society of Nephrology, April 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  11. Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines

    Article • Rheumatology, March 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  12. Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary

    Article • Rheumatology, February 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  13. Multimodal Imaging of Granulomatosis With Polyangiitis Aortitis Complicated by Severe Aortic Regurgitation and Complete Heart Block

    Article • Circulation Cardiovascular Imaging, February 2020, Wolters Kluwer Health

    Dr Stephen P McAdoo

  14. Membranous Glomerulonephritis With Crescents

    Article • Kidney International Reports, November 2019, Elsevier

    Dr Stephen P McAdoo

  15. Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In Vivo

    Article • Cell Reports, July 2019, Elsevier

    Dr Stephen P McAdoo

  16. IgG4-related disease in a multi-ethnic community: clinical characteristics and association with malignancy

    Article • QJM, June 2019, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  17. Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: reply

    Article • Rheumatology, March 2019, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  18. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis

    Article • Rheumatology, January 2019, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  19. Anti–Glomerular Basement Membrane Disease

    Article • Rheumatic Disease Clinics of North America, November 2018, Elsevier

    Dr Stephen P McAdoo

  20. Peroxidasin—a Novel Autoantigen in Anti-GBM Disease?

    Article • Journal of the American Society of Nephrology, October 2018, American Society of Nephrology

    Dr Stephen P McAdoo

  21. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis

    Article • Rheumatology, September 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  22. Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy

    Article • Seminars in Nephrology, September 2018, Elsevier

    Dr Stephen P McAdoo

  23. Antiglomerular Basement Membrane Disease

    Article • Seminars in Respiratory and Critical Care Medicine, August 2018, Thieme Publishing Group

    Dr Stephen P McAdoo

  24. Primary IgA nephropathy: current challenges and future prospects

    Article • International Journal of Nephrology and Renovascular Disease, April 2018, Dove Medical Press

    Dr Stephen P McAdoo, Rose Penfold

  25. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

    Article • Nephrology Dialysis Transplantation, March 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  26. Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab

    Article • Rheumatology, March 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  27. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

    Article • Nephrology Dialysis Transplantation, February 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  28. Deferiprone, an Iron Chelator, is Preventive and Therapeutic in Experimental Crescentic Glomerulonephritis

    Article • November 2017, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  29. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis

    Article • Clinical Journal of the American Society of Nephrology, November 2017, American Society of Nephrology

    Dr Stephen P McAdoo

  30. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

    Article • Kidney International, September 2017, Elsevier

    Dr Stephen P McAdoo, Sophie Ohlsson

  31. BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases

    Article • Nature Communications, July 2017, Springer Science + Business Media

    Dr Stephen P McAdoo

  32. Anti-Glomerular Basement Membrane Disease

    Article • Clinical Journal of the American Society of Nephrology, May 2017, American Society of Nephrology

    Dr Stephen P McAdoo

  33. Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?

    Article • Nephrology Dialysis Transplantation, January 2017, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  34. Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond

    Article • Nephrology Dialysis Transplantation, January 2017, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  35. P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB

    Article • Kidney International Reports, November 2016, Elsevier

    Dr Stephen P McAdoo

  36. ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap

    Article • Kidney International Reports, November 2016, Elsevier

    Dr Stephen P McAdoo

  37. Clustering of Anti-GBM Disease: Clues to an Environmental Trigger?

    Article • Clinical Journal of the American Society of Nephrology, July 2016, American Society of Nephrology

    Dr Stephen P McAdoo

  38. Ofatumumab for B cell depletion therapy in ANCA-associated vasculitis: a single-centre case series

    Article • Rheumatology, April 2016, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  39. Spleen Tyrosine Kinase: A Crucial Player and Potential Therapeutic Target in Renal Disease

    Article • January 2016, Karger Publishers

    Dr Stephen P McAdoo

  40. Renal tubular disease in the era of combination antiretroviral therapy

    Article • AIDS, September 2015, Wolters Kluwer Health

    Dr Stephen P McAdoo

  41. Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression

    Article • Kidney International, July 2015, Elsevier

    Dr Stephen P McAdoo

  42. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis

    Article • Ophthalmology, June 2015, Elsevier

    Dr Stephen P McAdoo

  43. Immunodeficiency-associated renal Burkitt lymphoma

    Article • British Journal of Haematology, November 2014, Wiley

    Dr Stephen P McAdoo

  44. Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series

    Article • Rheumatology, November 2014, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  45. Spleen Tyrosine Kinase Inhibition Attenuates Autoantibody Production and Reverses Experimental Autoimmune GN

    Article • Journal of the American Society of Nephrology, April 2014, American Society of Nephrology

    Dr Stephen P McAdoo

  46. Should Rituximab Be Used to Prevent Relapse in Patients with ANCA-Associated Vasculitis?

    Article • Clinical Journal of the American Society of Nephrology, March 2014, American Society of Nephrology

    Dr Stephen P McAdoo

  47. SYK inhibition in experimental autoimmune vasculitis and its glomerular expression in ANCA-associated vasculitis

    Article • The Lancet, February 2014, Elsevier

    Dr Stephen P McAdoo

  48. Anti-glomerular Basement Membrane Disease

    Article • January 2014, Springer Science + Business Media

    Dr Stephen P McAdoo

  49. Experimental crescentic glomerulonephritis: a new bicongenic rat model

    Article • Disease Models & Mechanisms, August 2013, The Company of Biologists

    Dr Stephen P McAdoo

  50. L46. Novel forms of clinical vasculitis: Anti-GBM vasculitis (Goodpasture's disease)

    Article • La Presse Médicale, April 2013, Elsevier

    Dr Stephen P McAdoo

  51. Spleen tyrosine kinase (SYK) inhibition in experimental autoimmune glomerulonephritis (EAG)

    Article • La Presse Médicale, April 2013, Elsevier

    Dr Stephen P McAdoo

  52. Focal necrotizing and crescentic glomerulonephritis in patients with normal serum creatinine

    Article • La Presse Médicale, April 2013, Elsevier

    Dr Stephen P McAdoo

  53. Proteinase-3 Antineutrophil Cytoplasm Antibody Positivity in Patients Without Primary Systemic Vasculitis

    Article • JCR Journal of Clinical Rheumatology, October 2012, Wolters Kluwer Health

    Prof Alan D Salama, Dr Stephen P McAdoo

  54. Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients

    Article • The Journal of Immunology, September 2012, The American Association of Immunologists

    Dr Stephen P McAdoo

  55. Acute renal failure in diabetes: looking beyond diabetic retinopathy

    Article • Clinical Medicine, December 2011, Royal College of Physicians

    Dr Stephen P McAdoo

  56. Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group

    Article • Nephrology Dialysis Transplantation, October 2011, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  57. Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody

    Article • Clinical Kidney Journal, April 2011, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  58. Fostamatinib disodium

    Article • Drugs of the Future, January 2011, Prous Science

    Dr Stephen P McAdoo

  59. Disease models of rapidly progressive glomerulonephritis

    Article • Drug Discovery Today Disease Models, March 2010, Elsevier

    Dr Stephen P McAdoo